72 torthaí

EU4Health Programme: extracts from the debate and the vote and statement by Cristian-Silviu BUŞOI (EPP, RO)
icon

04:50

Joint hearing of the ENVI and ITRE Committee - "How to increase the capacity of COVID 19 vaccine production and improve delivery": Q&A with ENVI and ITRE Members and CEOs of the pharmaceutical industry
icon

47:46

The state of play of the EU's COVID-19 vaccination strategy: MEPs debate (part 1)
icon

1:08:34

EU global strategy on COVID-19 vaccinations: MEPs debate 1/3
icon

35:35

Future relations between the EU and the UK: MEPs debate (part 2)
icon

40:58

Preparation of an EU Strategy on COVID-19 vaccination, including its external dimension: MEPs debate
icon

46:31

Pharmaceutical strategy for Europe: extracts from the debate
icon

04:16

Plenary session: EU measures to mitigate social and economic impact of Covid-19. MEPs debate
icon

1:07:59

Public Hearing on How to secure access to COVID-19 vaccines for EU citizens: clinical trials, production and distribution challenges. Joint EP Committee ENVI and ITRE. 1/2 Q&A with ENVI and ITRE Members.
icon

57:35

Conclusions of the extraordinary European Council meeting (17-21 July): MEPs debate (part 2)
icon

45:31

Vaccines and therapeutics in the context of Covid-19: First round political group leaders
icon

16:23

Conclusions of the extraordinary European Council meeting of 23 April 2020 and New MFF, own resources and Recovery plan: MEPs debate (part 2)
icon

30:56

Conclusions of the extraordinary European Council meeting of 23 April 2020 and New MFF, own resources and Recovery plan: MEPs debate (part 1)
icon

50:32

EU coordinated action to combat the COVID-19 pandemic and its consequences: MEPs debate (part 1)
icon

31:33

European coordinated response to the COVID-19 outbreak: MEPs debate (part 1)
icon

19:37

European Parliament's position on the Conference on the Future of Europe: MEPs debate (3rd part)
icon

1:09:16

Debate on the European Green Deal: MEPs debate (1/2) (14:57 - 15:33)
icon

35:06

Hearing of Kadri SIMSON, Commissioner-designate, Crisis Management: Questions and answers (Part 2)
icon

17:12